1. Home
  2. Our research into hearing loss and tinnitus
  3. Developing new treatments: the Hearing Therapeutics Initiative

Developing new treatments: the Hearing Therapeutics Initiative

RNID’s Hearing Therapeutics Initiative (HTI) is here to support innovators developing treatments for hearing loss and tinnitus. Join the network to help accelerate progress in this research.

What we offer

Scientific, clinical and market insight expertise: We can connect you to world-leading experts to access their advice, tailored to your specific innovation needs.

Strategic collaborations: We build relationships between biotech, academia, and investors creating new opportunities and partnerships.

Funding and research commercialisation support: From grant guidance to investor introductions, we help you secure the investment needed to advance your programmes.

Advocacy and visibility: We can showcase your work through events and across our communication channels – raising awareness and driving interest in your innovation.

Community: We help you stay connected – offering ongoing support and building a community that together can help shape the future of hearing therapeutics.

Join the HTI Network

By joining the network, you can access:

  • tailored support for your translational research
  • bi-monthly newsletters with updates on the hearing therapeutics sector
  • consulting and collaboration opportunities
  • invitations to HTI activities and events.

How the HTI is accelerating innovation

Read more about the strives in the hearing research field our Hearing Therapeutics Initiative have helped to make.

A woman in a laboratory wearing a white lab coat and putting liquid into a test tube. A graphic with the RNID logo inside a cog and the words "Hearing Therapeutics Initiative" are overlaid.

Contact us

As part of the HTI Network, you have access to our collective expertise. Connect with us for advice or insights on any area of hearing therapeutics development.
Get in touch

Page last updated: 5 December 2025

Back to top